| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| bevacizumab | Restricted |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA693 |
|||
| brentuximab vedotin | Nice-approved drug |
NICE TA478 NICE TA641 NICE TA524 NICE TA577 |
|||
| cetuximab | Restricted |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
|||
| ipilimumab | Nice-approved drug |
NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA724 NICE TA780 |
|||
| obinutuzumab | Nice-approved drug |
NICE TA343 NICE TA513 NICE TA629 |
|||
| panitumumab | Off Formulary |
NICE TA242 NICE TA439 |
|||
| polatuzumab vedotin | Restricted |
NICE TA649 |
|||
| rituximab | Restricted |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
| trastuzumab | Restricted |
NICE TA34 NICE TA257 NICE TA509 NICE TA208 |
|||
| trastuzumab emtansine | Restricted |
NICE TA458 NICE TA632 |
|||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| Bacillus Calmette-Guérin | Restricted | ||||
| interferon gamma-1b | Off Formulary | ||||
| lenalidomide | Restricted |
NICE TA322 NICE TA171 NICE TA505 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
| mifamurtide | Nice-approved drug |
NICE TA235 |
|||
| pomalidomide | Restricted |
NICE TA427 |
|||
| thalidomide | Restricted |
NICE TA228 |
|||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| afatinib | Nice-approved drug |
NICE TA310 |
|||
| aflibercept | Off Formulary |
NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307 |
|||
| axitinib | Restricted |
NICE TA333 NICE TA645 NICE TA650 |
|||
| bortezomib | Restricted |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
|||
| crizotinib | Restricted |
NICE TA406 NICE TA422 NICE TA529 |
|||
| dasatinib | Restricted |
NICE TA426 NICE TA425 |
|||
| erlotinib | Restricted |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
|||
| everolimus | Restricted |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| gefitinib | Restricted |
NICE TA192 NICE TA374 |
|||
| idelalisib | Restricted |
NICE TA359 NICE TA604 |
|||
| imatinib | Restricted |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
|||
| Tablet | |||||
| Imatinib (Non-proprietary) | Restricted | ||||
| Glivec (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||
| ixazomib | Nice-approved drug |
NICE TA505 |
|||
| lapatinib | Off Formulary |
NICE TA257 |
|||
| nilotinib | Restricted |
NICE TA426 NICE TA425 |
|||
| palbociclib | Off Formulary |
NICE TA495 NICE TA619 |
|||
| pazopanib | Restricted |
NICE TA215 |
|||
| ruxolitinib | Restricted |
NICE TA386 |
|||
| sorafenib | Restricted |
NICE TA178 NICE TA474 NICE TA535 |
|||
| sunitinib | Restricted |
NICE TA169 NICE TA179 NICE TA178 NICE TA449 |
|||
| temsirolimus | Off Formulary |
NICE TA178 |
|||
| vandetanib | Off Formulary |
NICE TA550 |
|||
| vemurafenib | Nice-approved drug |
NICE TA269 |
|||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| arsenic trioxide | Off Formulary |
NICE TA526 |
|||
| asparaginase | Restricted | ||||
| azacitidine | Restricted |
NICE TA399 NICE TA218 |
|||
| bendamustine hydrochloride | Restricted |
NICE TA216 NICE TA472 |
|||
| bexarotene | Off Formulary | ||||
| bleomycin | Restricted | ||||
| busulfan | Restricted | ||||
| cabazitaxel | Nice-approved drug |
NICE TA391 |
|||
| capecitabine | Restricted |
NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100 |
|||
| carboplatin | Restricted |
NICE TA284 NICE TA285 |
|||
| Solution for infusion | |||||
| Carboplatin (Non-proprietary) | Restricted | ||||
| carmustine | Restricted |
NICE TA121 |
|||
| chlorambucil | Restricted |
NICE TA343 NICE TA344 |
|||
| cisplatin | Restricted | ||||
| Solution for infusion | |||||
| Cisplatin (Non-proprietary) | Restricted | ||||
| cladribine | Restricted |
NICE TA616 |
|||
| Solution for infusion | |||||
| Leustat (Janssen-Cilag Ltd) | Off Formulary | ||||
| clofarabine | Restricted | ||||
| crisantaspase | Restricted | ||||
| Powder for solution for injection | |||||
| Erwinase (Porton Biopharma Ltd) | Off Formulary | ||||
| cyclophosphamide | Restricted | ||||
| cytarabine | Restricted | ||||
| Solution for injection | |||||
| Cytarabine (Non-proprietary) | Restricted | ||||
| dacarbazine | Restricted | ||||
| daunorubicin | Restricted | ||||
| decitabine | Off Formulary | ||||
| docetaxel | Restricted |
NICE TA101 NICE TA509 |
|||
| doxorubicin hydrochloride | Restricted |
NICE TA389 NICE TA465 |
|||
| Solution for infusion | |||||
| Caelyx (Baxter Healthcare Ltd) | Off Formulary | ||||
| epirubicin hydrochloride | Restricted | ||||
| estramustine phosphate | Restricted | ||||
| etoposide | Restricted | ||||
| Capsule | |||||
| Vepesid (Neon Healthcare Ltd) | Off Formulary | ||||
| Powder for solution for injection | |||||
| Etopophos (Neon Healthcare Ltd) | Off Formulary | ||||
| Solution for infusion | |||||
| Etoposide (Non-proprietary) | Restricted | ||||
| fludarabine phosphate | Restricted |
NICE TA119 NICE TA29 |
|||
| fluorouracil | Restricted | ||||
| gemcitabine | Restricted |
NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476 |
|||
| hydroxycarbamide | Restricted | ||||
| Tablet | |||||
| Siklos (Masters Pharmaceuticals Ltd) | Off Formulary | ||||
| Capsule | |||||
| Hydroxycarbamide (Non-proprietary) | Restricted | ||||
| Hydrea (Bristol-Myers Squibb Pharmaceuticals Ltd) | Off Formulary | ||||
| idarubicin hydrochloride | Restricted | ||||
| ifosfamide | Restricted | ||||
| Powder for solution for injection | |||||
| Ifosfamide (Non-proprietary) | Off Formulary | ||||
| irinotecan hydrochloride | Restricted |
NICE TA440 |
|||
| Solution for infusion | |||||
| Campto (Pfizer Ltd) | Off Formulary | ||||
| lomustine | Restricted | ||||
| Capsule | |||||
| Lomustine (Non-proprietary) | Restricted | ||||
| melphalan | Restricted | ||||
| mercaptopurine | Restricted | ||||
| methotrexate | Restricted | ||||
| Solution for injection | |||||
| Methotrexate (Non-proprietary) | Restricted | ||||
| Metoject PEN (medac UK) | Restricted | ||||
| Nordimet (Nordic Pharma Ltd) | Restricted | ||||
| mitomycin | Restricted | ||||
| Powder for solution for injection | |||||
| Mitomycin (Non-proprietary) | Restricted | ||||
| mitotane | Off Formulary | ||||
| mitoxantrone | Restricted | ||||
| Solution for infusion | |||||
| Mitoxantrone (Non-proprietary) | Restricted | ||||
| nelarabine | Off Formulary | ||||
| oxaliplatin | Restricted |
NICE TA100 NICE TA93 |
|||
| paclitaxel | Restricted |
NICE TA55 NICE TA284 NICE TA389 NICE TA476 |
|||
| Solution for infusion | |||||
| Paclitaxel (Non-proprietary) | Restricted | ||||
| pemetrexed | Restricted |
NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135 |
|||
| pentostatin | Restricted | ||||
| Powder for solution for injection | |||||
| Nipent (Pfizer Ltd) | Off Formulary | ||||
| pixantrone | Nice-approved drug |
NICE TA306 |
|||
| procarbazine | Restricted | ||||
| Capsule | |||||
| Procarbazine (Non-proprietary) | Restricted | ||||
| raltitrexed | Off Formulary | ||||
| tegafur with gimeracil and oteracil | Off Formulary | ||||
| temozolomide | Restricted |
NICE TA23 NICE TA121 |
|||
| Capsule | |||||
| Temodal (Merck Sharp & Dohme (UK) Ltd) | Off Formulary | ||||
| thiotepa | Off Formulary | ||||
| tioguanine | Restricted | ||||
| topotecan | Restricted |
NICE TA183 NICE TA184 NICE TA389 |
|||
| trabectedin | Nice-approved drug |
NICE TA185 NICE TA389 |
|||
| treosulfan | Restricted |
NICE TA640 |
|||
| tretinoin | Restricted | ||||
| vinblastine sulfate | Restricted | ||||
| Solution for injection | |||||
| Vinblastine sulfate (Non-proprietary) | Restricted | ||||
| vincristine sulfate | Restricted | ||||
| Solution for injection | |||||
| Vincristine sulfate (Non-proprietary) | Restricted | ||||
| vindesine sulfate | Off Formulary | ||||
| vinflunine | Off Formulary |
NICE TA272 |
|||
| vinorelbine | Restricted | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| dexrazoxane | Restricted | ||||
| folinic acid | Restricted |
NICE TA212 |
|||
| levofolinic acid | Off Formulary | ||||
| mesna | Restricted | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| rasburicase | Restricted | ||||
| Powder and solvent for solution for infusion | |||||
| Fasturtec (Sanofi) | Off Formulary | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| abiraterone acetate | Restricted |
NICE TA259 NICE TA387 NICE TA721 |
|||
| bicalutamide | Restricted | ||||
| Tablet | |||||
| Casodex (AstraZeneca UK Ltd) | Off Formulary | ||||
| cyproterone acetate | On Formulary | ||||
| Tablet | |||||
| Cyproterone acetate (Non-proprietary) | On Formulary | ||||
| degarelix | Nice-approved drug |
NICE TA404 |
|||
| diethylstilbestrol | Restricted | ||||
| Tablet | |||||
| Diethylstilbestrol (Non-proprietary) | Restricted | ||||
| enzalutamide | Nice-approved drug |
NICE TA316 NICE TA377 NICE TA580 NICE TA712 |
|||
| ethinylestradiol | Restricted | ||||
| flutamide | Restricted | ||||
| Tablet | |||||
| Flutamide (Non-proprietary) | Restricted | ||||
| goserelin | Restricted | ||||
| lanreotide | Restricted | ||||
| Solution for injection | |||||
| Somatuline Autogel (Ipsen Ltd) | Restricted | ||||
| Powder and solvent for suspension for injection | |||||
| Somatuline LA (Ipsen Ltd) | Off Formulary | ||||
| leuprorelin acetate | Restricted | ||||
| medroxyprogesterone acetate | Restricted | ||||
| Tablet | |||||
| Provera (Pfizer Ltd) | Off Formulary | ||||
| megestrol acetate | Restricted | ||||
| Tablet | |||||
| Megace (Bausch & Lomb UK Ltd) | Off Formulary | ||||
| norethisterone | Restricted | ||||
| octreotide | Restricted | ||||
| Solution for injection | |||||
| Sandostatin (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||
| triptorelin | Off Formulary | ||||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | Restricted | ||||
| Tablet | |||||
| Arimidex (AstraZeneca UK Ltd) | Off Formulary | ||||
| exemestane | Restricted | ||||
| Tablet | |||||
| Aromasin (Pfizer Ltd) | Off Formulary | ||||
| fulvestrant | Off Formulary |
NICE TA503 |
|||
| Solution for injection | |||||
| Faslodex (AstraZeneca UK Ltd) | Off Formulary | ||||
| letrozole | Restricted | ||||
| tamoxifen | Restricted | ||||
| toremifene | Off Formulary | ||||
| Malignant disease / Photodynamic therapy responsive malignancy | |||||
| porfimer sodium | Off Formulary | ||||
| temoporfin | Off Formulary | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| denosumab | Nice-approved drug |
NICE TA204 NICE TA265 |
|||
| ibandronic acid | Restricted |
NICE TA464 |
|||
| pamidronate disodium | On Formulary | ||||
| sodium clodronate | On Formulary | ||||
| zoledronic acid | Restricted |
NICE TA464 |
|||
| Infusion | |||||
| Aclasta (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||